Navigation Links
Achieving Optimal Performance from Single-Use Platforms, New Life Science Webinar Hosted by Xtalks
Date:3/11/2013

Toronto, Canada (PRWEB) March 11, 2013

Balancing flexibility and costs under an accelerated timeline is a challenge for any biotech firm. This webinar will describe the quality and regulatory points to consider, as well as the economic factors that support and justify expansion. Speakers from Fujifilm Diosynth Biotechnologies — a Contract Development & Manufacturing facility that has a successful history of supplying both clinical and commercial cell culture derived human therapeutics using stainless steel bioreactor platforms — will discuss the design basis for “all” single use manufacturing processes. They exploit the single use concept from ‘vial thaw through to bulk monoclonal antibody drug substance’.

The keys to maximizing the investment in a cGMP cell culture manufacturing facility and achieving operational benefits start during process development and initial process design.

This webinar will examine:

  •     The upstream and downstream development platforms that need to be modified and optimized to support efficient process definition and effective technology transfer to fully exploit single use bioprocess technologies. A case study involving Fujifilm Diosynth Biotechnologies’ cell line development will be presented.
  •     How upfront development of a robust single use process platform streamlines manufacturing operations and provides advantages in technology transfer via elegant process design
  •     How these advantages in operational robustness and process transfer efficiency allow for rapid process portability to enable manufacturing flexibility on a global scale

For more information about this event or to register, visit: http://xtks.in/xto574-event

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10499431.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
2. Ian Somerhalder Raises Big Money for the Environment; Optimal Chemical Comments His Effort Proves He's a True Green Celebrity
3. Cold Adds Up to Sandy Victims' Mold Problems; Optimal Chemical Reaches Out to Help by Advising the Use of Molderizer
4. Stoneville Cotton Seed from Bayer CropScience Celebrates 90 Years of Performance
5. Bayer CropScience and MS Technologies’ Balance GT Soybean to Usher in Next Era of Performance and Weed Control
6. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
7. New nanotech fiber: Robust handling, shocking performance
8. Thomson Reuters Online Resource Offers Key Trends in Scientific Research and Performance Analysis
9. Puritan Awarded U.S. Patent for High-Performance HydraFlock® Swab
10. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
11. Automated Online Sample Preparation Comes to Waters UltraPerformance Liquid Chromatography (UPLC) Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):